Natural Alternatives International Inc (NAII) stock
NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
$0.88−0.02 (-2.67%)
Close on Nov 20, 2026Market cap $19.37MP/E –Yield –
Natural Alternatives International operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Natural Alternatives International's operating income for the twelve months ending Jun 30, 2026 was -$18.75M. For fiscal 2026 it was -$18.75M. The highest annual figure on record is $13.68M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$18.75M | – |
| FY2025 | Jun 30, 2025 | -$8.66M | – |
| FY2024 | Jun 30, 2024 | -$8.53M | -281.1% |
| FY2023 | Jun 30, 2023 | $4.71M | -65.5% |
| FY2022 | Jun 30, 2022 | $13.68M | +0.1% |
| FY2021 | Jun 30, 2021 | $13.67M | – |
| FY2020 | Jun 30, 2020 | -$1.51M | -125.3% |
| FY2019 | Jun 30, 2019 | $5.96M | -37.5% |
| FY2018 | Jun 30, 2018 | $9.53M | -1.7% |
| FY2017 | Jun 30, 2017 | $9.70M | -20.9% |
| FY2016 | Jun 30, 2016 | $12.26M | +194.7% |
| FY2015 | Jun 30, 2015 | $4.16M | +49.8% |
| FY2014 | Jun 30, 2014 | $2.78M | +29.0% |
| FY2013 | Jun 30, 2013 | $2.15M | -65.3% |
| FY2012 | Jun 30, 2012 | $6.20M | +166.7% |
| FY2011 | Jun 30, 2011 | $2.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$13.18M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$4.01M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$1.85M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $284.00K | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$1.94M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$2.10M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$2.78M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$1.84M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$2.53M | -179.6% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$1.95M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$3.51M | -241.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$544.00K | -135.3% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $3.17M | -15.9% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$2.49M | -176.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $2.49M | +3.5% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $1.54M | -63.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $3.78M | +8.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $3.27M | +21.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $2.40M | -55.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $4.23M | +102.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $3.50M | +68.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $2.70M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $5.39M | +672.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $2.09M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.07M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$4.22M | -330.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $698.00K | -68.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$55.00K | -102.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$805.00K | -128.3% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.84M | -27.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $2.21M | -3.2% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $2.72M | +44.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $2.85M | +38.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $2.52M | +154.1% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $2.28M | -26.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.88M | -46.7% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $2.06M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $993.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $3.11M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $3.54M | – |
See a number that looks wrong?